NCT02967445

Brief Summary

Cervical insufficiency, previously referred to as cervical incompetence, has classically been defined as painless dilation of the cervix in the absence of contractions or bleeding in the second trimester resulting in recurrent pregnancy losses. Painless mid-trimester cervical dilation is an uncommon finding in the general population occurring in less than 1% of pregnancies. Cerclage for the prevention pregnancy loss in cases with both prior preterm births and/or second trimester losses, as well as second trimester cervical dilatation in the index pregnancy, was first reported in the 1950's. Cerclage placement in this setting has been variably referred to as "physical exam-indicated cerclage", "rescue cerclage", and "emergency cerclage". To date, the benefits of cerclage for this indication are not entirely clear. A recent meta-analysis showed that physical exam-indicated cerclage is associated with a reduction in perinatal mortality and prolongation of pregnancy when compared to no such cerclage. Recently, several RCTs have shown that cervical pessary could decrease the incidence of PTB in several populations. Thus, the aim of our trial as noninferiority trial is to evaluate the efficacy of pessary compared to cervical cerclage in prevention of PTB in women in the setting of mid-trimester cervical dilation

Trial Health

30
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Timeline
Completed

Started Nov 2016

Shorter than P25 for phase_3

Geographic Reach
1 country

1 active site

Status
withdrawn

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 1, 2016

Completed
10 days until next milestone

First Submitted

Initial submission to the registry

November 11, 2016

Completed
7 days until next milestone

First Posted

Study publicly available on registry

November 18, 2016

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2017

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2018

Completed
Last Updated

November 19, 2018

Status Verified

November 1, 2018

Enrollment Period

1.1 years

First QC Date

November 11, 2016

Last Update Submit

November 15, 2018

Conditions

Outcome Measures

Primary Outcomes (1)

  • Neonatal survival

    From delivery to 28 days

Secondary Outcomes (4)

  • Preterm birth

    time of delivery

  • Latency

    time of delivery

  • Birth weight

    time of delivery

  • gestational age at delivery

    time of delivery

Study Arms (2)

Cervical pessary

EXPERIMENTAL

Arabin Pessary

Device: Arabin Pessary

Cervical cerclage

ACTIVE COMPARATOR

McDonald Cerclage

Device: Cervical cerclage

Interventions

Arabin silicon pessary

Cervical pessary
Cervical cerclage

Eligibility Criteria

Age18 Years - 50 Years
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Singleton pregnancies
  • Cervical dilation between 1 to 5 cm and/or visible membranes by pelvic exam or speculum exam between at 16-23 6/7 weeks gestation

You may not qualify if:

  • Pessary or cerclage already in situ
  • active vaginal bleeding
  • Placenta previa/accreta
  • Multiple gestations
  • Amniotic membranes prolapsed beyond external os into the vagina, unable to visualize cervical tissue
  • Ruptured amniotic membranes at the time of diagnosis of dilated cervix
  • Cervical dilation more than 5 cm
  • Labor (progressing cervical dilation) or painful regular uterine contractions

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Gabriele Saccone

Napoli, 80129, Italy

Location

MeSH Terms

Conditions

Premature Birth

Interventions

Cerclage, Cervical

Condition Hierarchy (Ancestors)

Obstetric Labor, PrematureObstetric Labor ComplicationsPregnancy ComplicationsFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital Diseases

Intervention Hierarchy (Ancestors)

Obstetric Surgical ProceduresSurgical Procedures, Operative
0

Study Design

Study Type
interventional
Phase
phase 3
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
MD

Study Record Dates

First Submitted

November 11, 2016

First Posted

November 18, 2016

Study Start

November 1, 2016

Primary Completion

December 1, 2017

Study Completion

March 1, 2018

Last Updated

November 19, 2018

Record last verified: 2018-11

Locations